Skip to content

Effect of sweet violet flower in the treatment of atopic dermatitis in adults

Clinical evaluation of efficacy of Viola odorata flowers in the treatment of atopic dermatitis in adults

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
IRCT
Registry ID
IRCT201606143922N3
Enrollment
80
Registered
2016-06-20
Start date
2016-06-21
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Atopic dermatitis. Atopic dermatitis, unspecified

Interventions

Intervention 1: In intervention group, extract of sweet violet flower (capsule form) is given orally, 500 mg twice in a day for 14 consecutive days. Intervention 2: In control group, cetirizine is giv
Treatment - Drugs
In intervention group, extract of sweet violet flower (capsule form) is given orally, 500 mg twice in a day for 14 consecutive days.
In control group, cetirizine is given orally, 10 mg once a day for 14 consecutive days.

Sponsors

Kermanshah University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
12 Years to 70 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: acute, subacute and chronic atopic eczema with mild to moderate severity; patients older than 12 years. Exclusion criteria: pregnancy; lactation; other types of dermatitis other than atopic dermatitis; psoriasis; atopic dermatitis with severe severity.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Type of eczema. Timepoint: the first day of the study. Method of measurement: questionnaire.;Severity of eczema. Timepoint: the first day of the study, 14th day. Method of measurement: questionnaire.;Score of the disease. Timepoint: the first day of the study, 14th day. Method of measurement: questionnaire.

Secondary

MeasureTime frame
Side effects. Timepoint: during the study. Method of measurement: questionnaire.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDr. Masoud modarresi

Kermanshah University of Medical Sciences, Faculty of Pharmacy

mmodarresi@kums.ac.ir+98 83 3427 6489

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026